Scholarlink

Aims <p>To analyze the association between depressive symptoms and diabetes complications, stratified by metabolic control, in Mexican adults with type 2 diabetes mellitus.</p> Materials and methods <p>We analyzed data from adults aged 20 years and older with self-reported diabetes from the 2018–2019 Mexican National Health and Nutrition Survey (ENSANUT). Diabetes complications were categorized as microvascular, macrovascular, or other. Metabolic control was defined based on glycated hemoglobin, blood pressure, and cholesterol levels. Depressive symptoms were assessed using the CES-D7 scale. Logistic regression models were stratified by metabolic control to determine the association between complications and depressive symptoms, adjusting for relevant covariates.</p> Results <p>Among adults with poor metabolic control, depressive symptoms were significantly more prevalent in those with complications (47.2%, 95% CI: 46.4–53.9) than in those without (27.9%, 95% CI: 24.4–31.7). Among individuals with good metabolic control, the prevalence of depressive symptoms was higher in those with complications (48.8%, 95% CI: 34.6–63.2) than in those without (31.3%, 95% CI: 23.6–40.2), although the difference was not statistically significant. In those with poor metabolic control, both microvascular and other complications were significantly associated with depressive symptoms (adjusted odds ratios [<sub>adj</sub>OR] 2.3 [1.6–3.5] and 2.3 [1.4–3.7], respectively).</p> Conclusions <p>Poor metabolic control is associated with a higher prevalence of depressive symptoms, especially in patients with microvascular complications. These findings highlight the importance of integrating mental health screening and intervention into diabetes care to support emotional well-being and prevent adverse outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Poor glycemic control and microvascular complications: key drivers of depressive symptoms in adults with diabetes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月2日

查看全文
  • Consuelo Escamilla-Nuñez,
  • Rosalba Rojas-Martínez,
  • Carlos A. Aguilar-Salinas,
  • Martin Romero-Martínez,
  • Paloma Almeda-Valdés,
  • Lilia Castro-Porras

摘要

Aims

To analyze the association between depressive symptoms and diabetes complications, stratified by metabolic control, in Mexican adults with type 2 diabetes mellitus.

Materials and methods

We analyzed data from adults aged 20 years and older with self-reported diabetes from the 2018–2019 Mexican National Health and Nutrition Survey (ENSANUT). Diabetes complications were categorized as microvascular, macrovascular, or other. Metabolic control was defined based on glycated hemoglobin, blood pressure, and cholesterol levels. Depressive symptoms were assessed using the CES-D7 scale. Logistic regression models were stratified by metabolic control to determine the association between complications and depressive symptoms, adjusting for relevant covariates.

Results

Among adults with poor metabolic control, depressive symptoms were significantly more prevalent in those with complications (47.2%, 95% CI: 46.4–53.9) than in those without (27.9%, 95% CI: 24.4–31.7). Among individuals with good metabolic control, the prevalence of depressive symptoms was higher in those with complications (48.8%, 95% CI: 34.6–63.2) than in those without (31.3%, 95% CI: 23.6–40.2), although the difference was not statistically significant. In those with poor metabolic control, both microvascular and other complications were significantly associated with depressive symptoms (adjusted odds ratios [adjOR] 2.3 [1.6–3.5] and 2.3 [1.4–3.7], respectively).

Conclusions

Poor metabolic control is associated with a higher prevalence of depressive symptoms, especially in patients with microvascular complications. These findings highlight the importance of integrating mental health screening and intervention into diabetes care to support emotional well-being and prevent adverse outcomes.